Welcome to LookChem.com Sign In|Join Free
  • or
ethyl 2-[2-(4-fluorophenyl)-2-oxoethyl]sulfanylacetate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1152629-06-5

Post Buying Request

1152629-06-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1152629-06-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1152629-06-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,2,6,2 and 9 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1152629-06:
(9*1)+(8*1)+(7*5)+(6*2)+(5*6)+(4*2)+(3*9)+(2*0)+(1*6)=135
135 % 10 = 5
So 1152629-06-5 is a valid CAS Registry Number.

1152629-06-5Relevant academic research and scientific papers

An umpolung oxa-[2,3] sigmatropic rearrangement employing arynes for the synthesis of functionalized enol ethers

Gaykar, Rahul N.,George, Malini,Guin, Avishek,Bhattacharjee, Subrata,Biju, Akkattu T.

, p. 3447 - 3452 (2021/05/04)

An oxa-[2,3] sigmatropic rearrangement involving arynes is reported featuring the umpolung of ketones, where the C=O bond polarity is reversed. The in situ-generated sulfur ylides from β-keto thioethers and arynes undergo efficient rearrangement allowing the facile and robust synthesis of functionalized enol ethers in high yields and excellent functional group compatibility. Preliminary mechanistic studies rule out the possibility of Pummerer-type rearrangement operating in this case.

INHIBITORS OF APOL1 AND METHODS OF USING SAME

-

Paragraph 00472, (2020/07/14)

The disclosure provides at least one entity chosen from compounds of formula (I), solid state forms of the same, compositions comprising the same, and methods of using the same, including use in treating focal segmental glomerulosclerosis (FSGS) and/or non-diabetic kidney disease (NDKD).

Selection and development of a route for cholesterol absorption inhibitor AZD4121

Karlsson, Staffan,Soerensen, J. Henrik

scheme or table, p. 586 - 594 (2012/07/03)

The development of a synthetic route to the cholesterol absorption inhibitor AZD4121 is presented. Key steps are a highly enantioselective CBS reduction, a stereospecific Staudinger reaction, an amine/lithium chloride mediated ester hydrolysis, and a resolution of a 50:50 diastereomeric mixture by recrystallization. The synthesis was accomplished in 10 linear steps, and the overall yield, when compared with the lead optimization (LO) route, was improved from 1% to 20%. All purifications of intermediates through preparative HPLC or silica gel chromatography were avoided. This was possible since many of the intermediates along the route could be used as such in the next step until an intermediate with suitable crystalline properties could be identified and purified through crystallization.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1152629-06-5